Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?
Lof P, van de Vrie R, Korse CM, van Gent MDJM, Mom CH, Rosier-van Dunné FMF, van Baal WM, Verhoeve HR, Hermsen BBJ, Verbruggen MB, Hemelaar M, van de Swaluw AMG, Knipscheer HC, Huirne JAF, Westenberg SM, van der Noort V, Amant F, van den Broek D, Lok CAR. Lof P, et al. Among authors: van de swaluw amg. Gynecol Oncol. 2022 Aug;166(2):284-291. doi: 10.1016/j.ygyno.2022.05.025. Epub 2022 Jun 8. Gynecol Oncol. 2022. PMID: 35688656
Guideline adherence in ovarian cancer for surgical staging in the Netherlands.
Baldewpersad Tewarie NMS, van Ham M, Wouters M, Kruitwagen R, van Driel W; participants of the Dutch Gynecological Oncology Collaborator Group; participants of the Dutch Gynecological Oncology Collaborator Group. Baldewpersad Tewarie NMS, et al. Int J Gynecol Cancer. 2022 Dec 5;32(12):1592-1598. doi: 10.1136/ijgc-2022-003666. Int J Gynecol Cancer. 2022. PMID: 36270772
Clinical auditing as an instrument to improve care for patients with ovarian cancer: The Dutch Gynecological Oncology Audit (DGOA).
Baldewpersad Tewarie NMS, van Driel WJ, van Ham M, Wouters MW, Kruitwagen R; participants of the Dutch Gynecological Oncology Collaborator Group. Baldewpersad Tewarie NMS, et al. Eur J Surg Oncol. 2021 Jul;47(7):1691-1697. doi: 10.1016/j.ejso.2021.01.019. Epub 2021 Feb 5. Eur J Surg Oncol. 2021. PMID: 33581966 Free article.
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.
van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW. van Leeuwen FE, et al. Among authors: van de swaluw am. Hum Reprod. 2011 Dec;26(12):3456-65. doi: 10.1093/humrep/der322. Epub 2011 Oct 26. Hum Reprod. 2011. PMID: 22031719 Free PMC article.
Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit'.
Algera MD, van Driel WJ, Slangen BFM, Kruitwagen RFPM, Wouters MWJM; participants of the Dutch Gynecological Oncology Collaborator group. Algera MD, et al. Gynecol Oncol. 2022 May;165(2):330-338. doi: 10.1016/j.ygyno.2022.02.013. Epub 2022 Feb 22. Gynecol Oncol. 2022. PMID: 35221132 Free PMC article.